Gerrit Dispersyn - 16 Aug 2021 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
16 Aug 2021
Net transactions value
+$9,780
Form type
4
Filing time
17 Aug 2021, 09:11:24 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $9,780 +6,000 +6.7% $1.63 95,281 16 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.